Hutchings, M., Sureda, A., Bosch, F., Larsen, T. S., Corradini, P., Avigdor, A., Terol, M. J., Dominguez, A. R., Pinto, A., Skarbnik, A., Córdoba, R., Jørgensen, J. M., Zinzani, P. L., Leung, W., Bottos, A., Li, D., Relf, J., Tandon, M., Sellam, G., Gritti, G. (2025). Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00992